Form 4 for BBIO BridgeBio Pharma, Inc.
Accepted 2025-02-19 00:00:00 ET · period of report 2025-02-16 · accession 0000950170-25-023632 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-19 | 2025-02-16 | BBIO | Trimarchi Thomas | Pres, COO | F - Tax | $34.90 | -13.8K | 414.2K | -3% | -$481.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-16 | F | D | 13,782 | $34.90 | 414,205 | D | — | — | (F1) Represents the number of shares of the Issuer's Common Stock withheld by the Issuer to satisfy the Reporting Person's tax obligation in connection with the vesting of 32,431 shares of Common Stock underlying the Reporting Person's Restricted Stock Units. |